Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer

Author:

Rugo Hope S.1,Im Seock-Ah2,Cardoso Fatima3,Cortés Javier45,Curigliano Giuseppe6,Musolino Antonino7,Pegram Mark D.8,Wright Gail S.9,Saura Cristina10,Escrivá-de-Romaní Santiago10,De Laurentiis Michelino11,Levy Christelle12,Brown-Glaberman Ursa13,Ferrero Jean-Marc14,de Boer Maaike15,Kim Sung-Bae16,Petráková Katarína17,Yardley Denise A.18,Freedman Orit19,Jakobsen Erik H.20,Kaufman Bella21,Yerushalmi Rinat22,Fasching Peter A.23,Nordstrom Jeffrey L.24,Bonvini Ezio24,Koenig Scott24,Edlich Sutton24,Hong Shengyan24,Rock Edwin P.24,Gradishar William J.25,

Affiliation:

1. University of California San Francisco Helen Diller Family Comprehensive Cancer Center

2. Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea

3. Champalimaud Clinical Center/Champalimaud Foundation, Breast Unit, Lisbon, Portugal

4. IOB Institute of Oncology, Quironsalud Group, Madrid and Barcelona, Spain

5. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain

6. European Institute of Oncology, IRCCS, Division of Early Drug Development, University of Milano, Milan, Italy

7. Department of Medicine and Surgery, University of Parma, Medical Oncology and Breast Unit, University Hospital of Parma, Parma, Italy

8. Stanford Comprehensive Cancer Institute, Stanford University School of Medicine, Stanford, California

9. Florida Cancer Specialists & Research Institute, New Port Richey

10. Vall d’Hebron University Hospital and Vall d’Hebron Institute of Oncology (VHIO), Medical Oncology Service, Barcelona, Spain

11. Department of Breast and Thoracic Oncology, Istituto Nazionale Tumori “Fondazione Pascale”, Naples, Italy

12. Centre François Baclesse, Institut Normand du Sein, Caen, France

13. Division of Hematology/Oncology, University of New Mexico Comprehensive Cancer Center, Albuquerque

14. Centre Antoine Lacassagne, Department of Medical Oncology, University Côte d’Azur, Nice, France

15. Maastricht University Medical Center, Division of Medical Oncology, Department of Internal Medicine, GROW-School of Oncology and Developmental Biology, Maastricht, the Netherlands

16. Department of Oncology, Asan Medical Center, Seoul, Korea

17. Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic

18. Sarah Cannon Research Institute, Tennessee Oncology PLLC, Nashville

19. RS McLaughlin Durham Regional Cancer Centre, Lakeridge Health, Oshawa, Ontario, Canada

20. Department of Oncology, Vejle Hospital, Vejle, Denmark

21. Chaim Sheba Medical Center, Breast Oncology Institute, Ramat Gan, Israel

22. Davidoff Cancer Center, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel

23. Erlangen University Hospital, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Department of Gynecology and Obstetrics, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany

24. MacroGenics, Inc, Rockville, Maryland

25. Division of Hematology/Oncology, Northwestern University, Chicago, Illinois

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3